EMA Authorised: DaTSCAN (ioflupane (123l)) — GE Healthcare B.V.

View source ↗

Summary

EMA authorised DaTSCAN, a radiopharmaceutical imaging agent (ioflupane I-123) by GE Healthcare B.V., for use in the diagnostic assessment of Parkinson's disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Lewy Body Dementia
• Parkinson Disease

Drugs mentioned

• DaTscan (ioflupane)

Snippet

Status: Authorised. Therapeutic area: Tomography, Emission-Computed, Single-Photon;Lewy Body Disease;Parkinson Disease;Alzheimer Disease. MAH: GE Healthcare B.V.. Decision date: 22/01/2026